Chemerin, which is primarily expressed in TAMs and partially expressed in GBM cells, promoted the mesenchymal characteristics of GBM by inhibiting the ubiquitin-proteasomal degradation of CMKLR1, increasing NF-κB pathway activation in the process.71 Here, NFKB1 is linked to glioblastoma.